Paul Sowyrda

Corporate Board Member

Paul Sowyrda is an accomplished executive and inventor with over 30 years of experience in the pharmaceutical and biotechnology sectors. He co-founded Novellus, Inc. and served as its Executive Vice President until its acquisition by Brooklyn ImmunoTherapeutics in 2021. Paul has held key leadership roles, including Vice President of Drug Development at CIBA, Vice President of Development and Marketing at Dusa Pharmaceuticals, and Vice President of Product Development for Chiron Corporation.

A prolific inventor, he holds more than 15 patents across various fields, demonstrating his commitment to innovation. Paul has also contributed to the industry through his service on the Board of Directors for The Society of Concurrent Product Development and as a member of both the American Academy of Dermatology and the International Society of Dermatologic Surgery.

He earned his B.S. from Northeastern University, an M.S. from the University of Notre Dame, and an MBA from Babson College, along with completing the MIT Sloan School of Management Senior Executives Program. Paul resides in Boston and is actively involved in advancing cellular therapy solutions.